Press release
Parkinson's Disease Therapeutic Market Regional Performance and Global Forecast 2026 to 2035
According to the latest research by InsightAce Analytic, the Global Parkinson's Disease Therapeutic Market Size is valued at USD 5.22 billion in 2025 and is predicted to reach USD 9.46 billion by the year 2035 at a 6.5% CAGR during the forecast period for 2026 to 2035.
Get A Free Report Brochure:
https://www.insightaceanalytic.com/request-sample/2587
Parkinson's disease (PD) is a progressive neurodegenerative disorder that primarily impairs motor function and significantly impacts patients' quality of life. Current treatment strategies are largely symptomatic, aiming to manage disease manifestations and improve daily functioning rather than provide a definitive cure. The Parkinson's disease treatment market is expanding, supported by increasing disease awareness and improved rates of early diagnosis. Advances in diagnostic technologies, including high-resolution neuroimaging techniques and the development of validated biomarkers, are enabling earlier and more accurate detection, which in turn facilitates timely therapeutic intervention and improved clinical outcomes.
In addition, rising investments in research and development by pharmaceutical companies and government organizations are fostering innovation in treatment approaches. Collaborative efforts between biotechnology firms, research institutes, and academic organizations are accelerating the discovery and development of novel therapeutics. Moreover, the growing adoption of digital health technologies-such as wearable monitoring systems and telemedicine platforms-is strengthening disease management frameworks, improving patient monitoring, and enhancing adherence to prescribed treatment regimens, thereby contributing to sustained growth in the market.
List of Prominent Players in the Parkinson's Disease Therapeutic Market:
• Teva Pharmaceutical Industries Ltd.,
• Novartis AG
• GlaxoSmithKline Plc.
• AbbVie Inc.
• Merck & Co. Inc.,
• Zydus Cadila
• Dr. Reddy's
• Sun Pharmaceutical Industries Ltd.
• Cipla Inc.
• Boehringer Ingelheim International GmbH
• Denali Therapeutics Inc.
• Biogen Inc.
• Prevail Therapeutics
• Eli Lilly and Company
• Voyager Therapeutics.
• Intas Pharmaceuticals Ltd.
• Torrent Pharmaceuticals Ltd.
• Amneal Pharmaceuticals
• Aurobindo Pharma Limited
• Accord Healthcare Ltd.
Market Dynamics:
Drivers-
The growth of the global Parkinson's disease (PD) therapeutics market is primarily driven by the increasing prevalence of the condition worldwide. Improved disease awareness combined with advancements in diagnostic technologies has enabled earlier and more accurate detection, thereby expanding the demand for effective treatment options. The availability of a broad range of therapeutic interventions, designed to address different stages and severity levels of the disease, is further contributing to better patient management and overall market expansion.
Read Report Overview
https://www.insightaceanalytic.com/report/parkinsons-disease-therapeutic-market/2587
Challenges:
One of the major challenges in the Parkinson's disease therapeutics market is the declining rate of new drug approvals from regulatory authorities. This trend limits the introduction of novel treatment options, thereby restricting therapeutic advancements available to patients and healthcare providers. The reduced pipeline of approved drugs may also decrease market competition, potentially leading to higher treatment costs. As a result, this slowdown in innovation poses a barrier to improving care standards and addressing the complex and evolving needs of individuals living with Parkinson's disease.
Regional Trends:
North America dominates the global Parkinson's disease therapeutics market, supported by a high disease burden, particularly within the aging population. The United States leads the region due to its well-established healthcare infrastructure, strong awareness programs, and advanced treatment adoption rates. Europe also holds a significant market share, driven by a strong economic foundation, increasing uptake of innovative therapies, and active initiatives from key industry stakeholders. Furthermore, strategic collaborations among pharmaceutical and biotechnology companies are strengthening market presence across the region, thereby creating additional growth opportunities within the global Parkinson's disease therapeutics sector.
Recent Developments:
• In March 2024, Sanofi and Cipla have formed an exclusive collaboration to distribute and promote Sanofi India's Central Nervous System (CNS) product range in India. Under this collaboration, Cipla will assume the responsibility of distributing Sanofi India's six CNS brands, which includes Frisium®, a prominent brand in the anti-epileptic drug field.
• In Oct 2022, Biogen and Denali Therapeutics commenced the Phase 3 LIGHTHOUSE Study in Parkinson's Disease linked to LRRK2 Pathogenic Mutations. The main objective of the LIGHTHOUSE trial was to measure the duration until proven deterioration, evaluated using the Movement Disorder Society-Sponsored Revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS), during the treatment term of up to 180 weeks.
Add our site to Google Preferred Sources for quality content : https://google.com/preferences/source?q=insightaceanalytic.com
Segmentation of Parkinson's Disease Therapeutic Market-
By Drugs
• Carbidopa-levodopa
• Dopamine agonists
• Mao-b inhibitors
• COMT inhibitors
• Anticholinergics
• Others
By Distribution Channel-
• Hospital pharmacy
• Retail pharmacy
• Online pharmacy
By Brand
• Branded
• Generics
By Route of Administration
• Oral,
• Injectable,
• Intestinal Infusion,
• Subcutaneous
• Others
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of Middle East and Africa
Get Specific Chapter/Information From The Report:
https://www.insightaceanalytic.com/customisation/2587
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
Contact Us:
info@insightaceanalytic.com
InsightAce Analytic Pvt. Ltd.
Official Site Visit: www.insightaceanalytic.com
Tel.: +1 607 400-7072
Email: info@insightaceanalytic.com
Follow US On :
LinkedIn @ https://www.linkedin.com/company/insightace-analytic-pvt-ltd/
Twitter @ https://x.com/MInsightace
YouTube @ https://www.youtube.com/@InsightAceAnalytic
Instagram @https://www.instagram.com/insight_ace_analytic/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Parkinson's Disease Therapeutic Market Regional Performance and Global Forecast 2026 to 2035 here
News-ID: 4523307 • Views: …
More Releases from Insightace Analytic Pvt Ltd.
Pharmacodynamic Biomarker Assays, Platforms & Services Market Future Landscape a …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Pharmacodynamic Biomarker Assays, Platforms & Services Market Size, Share & Trends Analysis Report by Testing Type (Pharmacokinetics, Pharmacodynamics, Bioequivalence, Other Tests), by Modality Type (Monoclonal Antibodies, Cell Therapies, Gene Therapies, Biosimilars, Fusion Proteins, Traditional Viral-Based Therapies, Other Biologics), by End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations (CROs) / Contract Development and Manufacturing Organizations…
Pollution-Free Construction Market Top Companies Study - Holcim Group, Heidelber …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Pollution Free Construction Market (By Construction Type: Residential, Commercial, Industrial, Infrastructure; By Material Type: Low-carbon Cement & Concrete, Recycled Materials, Sustainable Wood & Bamboo, Green Insulation Materials, Low-VOC Paints & Coatings; By Technology: Prefabrication / Modular construction, 3D Printing Construction, Green Building Design, Smart Construction Technologies; By Energy & Resource Systems: Renewable Energy Systems, Water…
Molecular Oncology Diagnostics Market Revenue Trends and Growth Potential 2026 t …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Molecular Oncology Diagnostics Market Size, Share & Trends Analysis Report By Product (Kits and Assays, Instruments, Software), By Technology (Polymerase Chain Reaction, Next-Generation Sequencing, Immunohistochemistry, Fluorescence In-Situ Hybridization, Flow Cytometry, Other Technologies), By Application (Clinical Diagnostics, Research Use), By Cancer Type (Solid Tumors, Hematologic Malignancies), By End User (Hospitals and Diagnostic Centers, Reference Laboratories, Pharmaceutical…
eSAF / Power-to-Liquid (PtL) Market Key Players Analysis - Twelve, Infinium, Zaf …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " "Global eSAF / Power-to-Liquid (PtL) Market Size, Share & Trends Analysis Report by Conversion Technology (Fischer-Tropsch PtL, Methanol-to-Jet, Direct CO2-Electrolysis & Upgrading, Solar-Thermochemical & Other Emerging Routes), by CO2 Feedstock Source (Biogenic Point-Source, Industrial / Unavoidable Point-Source, Direct Air Capture), by Hydrogen Supply Model (Captive / On-Site Electrolysis, Merchant / Contracted Green Hydrogen), by Sales…
More Releases for Parkinson
Key Trends Reshaping the Wolff Parkinson White Syndrome Market: Technological Ad …
Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.
Wolff Parkinson White Syndrome Market Size Growth Forecast: What to Expect by 2025?
The market for Wolff Parkinson White syndrome has registered consistent growth over the recent past. The expectation is that it will expand from $1.17 billion in 2024 to $1.22 billion in 2025, reflecting a compound annual growth rate (CAGR) of 4.5%.…
Evolving Market Trends In The Anti-Parkinson Drugs Industry: Innovative Advancem …
The Anti-Parkinson Drugs Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Anti-Parkinson Drugs Market Size During the Forecast Period?
The anti-parkinson drugs market has seen significant growth in recent years, projected to increase from $10.37 billion in 2024 to $11.08 billion in…
What's Driving the Anti-Parkinson Drugs Market 2025-2034: Increasing Geriatric P …
What Are the Projections for the Size and Growth Rate of the Anti-Parkinson Drugs Market?
In recent times, the market size for anti-Parkinson drugs has experienced robust growth. The market, which is projected to rise from $10.37 billion in 2024 to $11.08 billion in 2025, boasts a compound annual growth rate (CAGR) of 6.9%. The past growth trend can be credited to an aging demographic, a surge in disease incidence, enhanced…
What's Driving the Anti-Parkinson Drugs Market 2025-2034: Increasing Geriatric P …
What Are the Projections for the Size and Growth Rate of the Anti-Parkinson Drugs Market?
In recent times, the market size for anti-Parkinson drugs has experienced robust growth. The market, which is projected to rise from $10.37 billion in 2024 to $11.08 billion in 2025, boasts a compound annual growth rate (CAGR) of 6.9%. The past growth trend can be credited to an aging demographic, a surge in disease incidence, enhanced…
Anti-Parkinson Drugs Market Overview
Exhibiting robust growth, the anti-parkinson drugs market is set to escalate from $9.73 billion in 2023 to $10.43 billion in 2024, with a notable Compound Annual Growth Rate (CAGR) of 7.2%. The trajectory continues on an upward trend, with an anticipated market size of $13.36 billion by 2028, sustaining a robust CAGR of 6.4%.
Increasing Geriatric Population Driving Demand:
The burgeoning geriatric population, coupled with a surge in Parkinson's disease cases,…
QualitySolicitors Parkinson Wright invest in the future
QualitySolicitors Parkinson Wright has selected Liberate from Linetime as its business-wide legal services software platform. The Worcestershire based practice, with over 100 staff, operate from 4 offices and have a highly regarded reputation for their services including residential property, private client, family, dispute resolution and commercial. The firm also has its own estate agency.
The firm recognised that to continue delivering high quality services to its clients it needed to provide…
